Titlebook: Defects in T Cell Trafficking and Resistance to Cancer Immunotherapy; Emmanuel Donnadieu Book 2016 Springer International Publishing Switz

只看該作者 · 發(fā)表于 2025-3-25 07:01:19

Book 2016py is starting to transform the treatment of advanced cancers.?However, despite recent successes, many patients with cancer fail to respond to these treatments. Defective migration of T cells into and within tumors is considered as an important resistance mechanism to cancer immunotherapy.The volume

只看該作者 · 發(fā)表于 2025-3-25 10:43:10

只看該作者 · 發(fā)表于 2025-3-25 13:30:05

只看該作者 · 發(fā)表于 2025-3-25 19:32:52

只看該作者 · 發(fā)表于 2025-3-25 20:47:25

Emmanuel DonnadieuGives the latest research on specific defects in T cell trafficking, which hinder the success of cancer immunotherapy.Provides the basic priniciples to T cell migration during efficient immune respons

只看該作者 · 發(fā)表于 2025-3-26 00:09:56

只看該作者 · 發(fā)表于 2025-3-26 07:08:35

只看該作者 · 發(fā)表于 2025-3-26 10:40:15

只看該作者 · 發(fā)表于 2025-3-26 13:22:47

M. D. Maines,M. J. Tomio,V. Janouseketed immunotherapies. Treatments, such as cancer vaccines, CAR T cells and immune checkpoint inhibitors, aim to activate and harness T cells against cancer. However, tumors induce pathological angiogenesis and, at the same time, condition the tumor blood vessels to form a tumor vascular network that

只看該作者 · 發(fā)表于 2025-3-26 20:46:31

		自動(dòng)登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評(píng)	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-19 23:34
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved